Aurobindo Pharma gets USFDA nod for infections treatment drug

The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Azithromycin Oral suspension 100 mg /5 mL and 200 mg/5 mL.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2EgTYZd
via IFTTT